Novel imantib resistance mechanisms in chronic myloid leukemia

Novel imantib resistance mechanisms in chronic myloid leukemia

In my research, I found that the compensatory activation of PI3K/AKT/mTor signaling pathway contributes early imatinib resistance in LAMA cell models. We also found that the auto/paracrine of GM-CSF by imatinib resistant leukemic cells confers to potent imatinib and nilotinib resistance. These findi...

Full description

Saved in:
Bibliographic Details
Main Author: Wang, Ying
Contributors: Neubauer, Andreas (Prof. Dr.) (Thesis advisor)
Format: Doctoral Thesis
Language:English
Published: Philipps-Universität Marburg 2007
Subjects:
Chronic myeloid leukaemia
Medizin
GM-CSF
Imatinib resistance
PI3K/Akt pathway
Conditioned medium
Medical sciences Medicine
Online Access:PDF Full Text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In my research, I found that the compensatory activation of PI3K/AKT/mTor signaling pathway contributes early imatinib resistance in LAMA cell models. We also found that the auto/paracrine of GM-CSF by imatinib resistant leukemic cells confers to potent imatinib and nilotinib resistance. These findings may serve as a novel strategy to overcome disease resistance to imatinib.
Physical Description:88 Pages
DOI:10.17192/z2007.0309

Similar Items